The prognostic value of multiparameter flow cytometry minimal residual disease assessment in relapse multiple myeloma

Paiva B (1), Chandia M (2), Puig N (3), Vidriales MB (2), Perez JJ (2), Lopez-Corral L (2), Ocio EM (4), Garcia-Sanz R (2), Gutierrez NC (2), Jimenez-Ubieto A (5), Lahuerta JJ (6), Mateos MV (2), San Miguel JF (7).

(1) Clinica Universidad de Navarra, Spain;
(2) Hospital Universitario de Salamanca, Spain;
(3) University Hospital of Salamanca, Spain;
(4) Hospital Universitario, Spain;
(5) Hospital 12 de Octubre, Madrid, Spain;
(6) Hospital 12 de Octubre, Madrid. Spain.
(7) Clinica Universidad de Navarra, Spain